Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$555M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$435M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$428M |
| 4 |
Accenture
ACN
|
+$402M |
| 5 |
Fortive
FTV
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$535M |
| 2 |
NVIDIA
NVDA
|
+$518M |
| 3 |
Coca-Cola
KO
|
+$488M |
| 4 |
AT&T
T
|
+$474M |
| 5 |
Meta Platforms (Facebook)
META
|
+$461M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.74% |
| 2 | Healthcare | 2.42% |
| 3 | Financials | 2.31% |
| 4 | Consumer Discretionary | 1.76% |
| 5 | Industrials | 1.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KNDI
10151
CALL
Kandi Technologies Group
KNDI
$63M
| $345K | ﹤0.01% |
107,700
-85,500
| -44% | -$272K |
|
|
TGNA
10152
PUT
DELISTED
TEGNA Inc
TGNA
| $345K | ﹤0.01% |
15,400
-16,200
| -51% | -$340K |
|
|
HGEN
10153
PUT
DELISTED
HUMANIGEN, INC.
HGEN
| $345K | ﹤0.01% |
114,700
+68,300
| +147% | +$183K |
|
10154
Alnylam Pharmaceuticals
ALNY
$30.6B
| $344K | ﹤0.01% |
2,108
-68,660
| -97% | -$10.5M |
|
10155
PUT
C4 Therapeutics
CCCC
$522M
| $344K | ﹤0.01% |
+14,200
| New | +$345K |
|
10156
CALL
CoreCivic
CXW
$3.25B
| $344K | ﹤0.01% |
30,800
-147,200
| -83% | -$1.44M |
|
|
KYNB
10157
PUT
Kyntra Bio
KYNB
$28.5M
| $344K | ﹤0.01% |
1,144
+88
| +8% | +$30.7K |
|
10158
Virtus Terranova US Quality Momentum ETF
JOET
$253M
| $344K | ﹤0.01% |
+11,442
| New | +$339K |
|
10159
S&T Bancorp
STBA
$1.8B
| $344K | ﹤0.01% |
+11,642
| New | +$366K |
|
|
PETQ
10160
PUT
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $344K | ﹤0.01% |
14,100
-10,700
| -43% | -$225K |
|
|
CPUH
10161
CALL
DELISTED
Compute Health Acquisition Corp.
CPUH
| $344K | ﹤0.01% |
35,200
+7,400
| +27% | +$72.2K |
|
10162
PUT
ARKO Corp
ARKO
$544M
| $343K | ﹤0.01% |
37,700
+21,600
| +134% | +$182K |
|
|
BRY
10163
DELISTED
Berry Corp
BRY
| $343K | ﹤0.01% |
33,222
-78,443
| -70% | -$744K |
|
10164
Cipher Digital
CIFR
$7.41B
| $343K | ﹤0.01% |
94,232
+84,174
| +837% | +$270K |
|
10165
NRC Health Common Stock
NRC
$469M
| $343K | ﹤0.01% |
8,655
-14,593
| -63% | -$571K |
|
10166
PUT
VanEck Pharmaceutical ETF
PPH
$985M
| $343K | ﹤0.01% |
4,300
+400
| +10% | +$30.6K |
|
10167
CALL
Pixelworks
PXLW
$42.2M
| $343K | ﹤0.01% |
9,633
+1,508
| +19% | +$59.9K |
|
10168
CALL
Veru
VERU
$46.5M
| $343K | ﹤0.01% |
7,110
+620
| +10% | +$33.7K |
|
|
ENDP
10169
PUT
DELISTED
Endo International plc
ENDP
| $343K | ﹤0.01% |
148,300
-126,800
| -46% | -$372K |
|
|
GREK
10170
Global X MSCI Greece ETF
GREK
$334M
| $342K | ﹤0.01% |
+12,865
| New | +$351K |
|
10171
PUT
Limoneira
LMNR
$251M
| $342K | ﹤0.01% |
23,300
+4,900
| +27% | +$71.3K |
|
|
DFTX
10172
CALL
Definium Therapeutics
DFTX
$5.73B
| $342K | ﹤0.01% |
20,520
+5,300
| +35% | +$92K |
|
10173
PUT
Primerica
PRI
$9.65B
| $342K | ﹤0.01% |
2,500
-2,600
| -51% | -$369K |
|
|
AXLA
10174
CALL
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $342K | ﹤0.01% |
5,316
+264
| +5% | +$13.2K |
|
|
BGRY
10175
CALL
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $342K | ﹤0.01% |
118,900
+5,200
| +5% | +$18.5K |
|
Similar funds
Ken Griffin's Q1 2022 Portfolio in Review
As of Q1 2022, Ken Griffin held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.
- Ken Griffin's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
- Ken Griffin's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
- Ken Griffin fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
- Ken Griffin's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
- Ken Griffin opened 1,669 new positions and closed 1,922 in Q1 2022.
- Ken Griffin's portfolio value fell 1% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.